‘MARRVEL’: a new way to compile big data in a human-centric way
When a group of researchers in the Undiagnosed Disease Network at Baylor College of Medicine realized they were spending days combing through databases searching for information regarding gene variants, they decided to do something about it. They created MARRVEL (Model organism Aggregated Resources for Rare Variant ExpLoration) to help not only their own lab but also researchers everywhere search databases all at once and in a matter of minutes.
Big data search engine
“One big problem we have is that tens of thousands of human genome variants and phenotypes are spread throughout a number of databases, each one with their own organization and nomenclature that aren’t easily accessible,” said Julia Wang. “MARRVEL is a way to assess the large volume of data, providing a concise summary of the most relevant information in a rapid user-friendly format.”
MARRVEL displays information from OMIM, ExAC, ClinVar, Geno2MP, DGV, and DECIPHER, all separate databases to which researchers across the globe have contributed, sharing tens of thousands of human genome variants and phenotypes. Since there is not a set standard for recording this type of information, each one has a different approach and searching each database can yield results organized in different ways. Similarly, decades of research in various model organisms, from mouse to yeast, are also stored in their own individual databases with different sets of standards.
Dr. Zhandong Liu explains that MARRVEL acts similar to an internet search engine.
“This program helps to collate the information in a common language, drawing parallels and putting it together on one single page. Our program curates specific databases of model organisms to concurrently display a concise summary of the data,” Liu said.
A user can first search for a gene or variant, Wang explains. Results may include what is known about this gene overall, whether or not that gene is associated with a disease, whether it is highly occurring in the general population and how it is affected by certain mutations.
“MARRVEL helps to facilitate analysis of human genes and variants by cross-disciplinary integration of 18 million records so we can speed up the discovery process through computation,” Liu said. “All this information is basically inaccessible unless researchers can access it efficiently and apply it to their own work to find causes, treatments and hopefully identify new diseases.”
This project started as a necessity for the Model Organism Screening Center for the Undiagnosed Disease Network at Baylor, but as it grew, the group began reaching out to researchers in different disciplines for feedback on how MARRVEL might benefit them.
“This program is just the start. I think our tool is going to be a model for us to help clinicians and basic scientists more efficiently use the information already publicly available,” Wang said. “It will help us understand and process all of the different mutations that researchers are discovering.”
“The most exciting part is how this project is bringing so many different researchers together,” Liu said. “We are working with labs we might not have normally collaborated with, trying to put together a puzzle of all this data.”
Both Wang and Liu are thankful to the contributions from the genetics communities allowing them access to the databases as they developed MARRVEL.
To read an interview with the authors of this paper, visit the American Society for Human Genetics blog
Others who contributed to the findings include Drs. Rami Al-Ouran, Seon Young Kim, Ying-Wooi Wan, Michael Wangler, Shinya Yamamoto, Hsiao-Tuan Chao, and Hugo Bellen (Howard Hughes Medical Institute at Baylor) all with Baylor College of Medicine; Yanhui Hu, Aram Comjean, Stephanie E. Mohr, and Norbert Perrimon (Howard Hughes Medical Institute at Harvard Medical School) all with Harvard Medical School.
For full funding and acknowledgements, please see full publication in the American Journal of Human Genetics.
This is a collaborative effort among Baylor, the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (NRI) and Harvard Medical School.
Julia Wang is an M.D./Ph.D. candidate in the Medical Scientist Training Program at Baylor and a McNair Student Scholar in the Bellen lab, as well as first author on the publication.
Dr. Zhandong Liu, assistant professor in pediatrics – neurology at Baylor, a member of the NRI and co-corresponding author on the publication.